Here is the latest stock price and chart of BETA DRUGS . For more details, see the BETA DRUGS company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
India's Capex Comeback: Explore Small Cap Stock Opportunities
Live BSE Quotes |
---|
Not listed |
Live NSE Quotes | May 18, 2024 (Close) | ||
---|---|---|---|
Price (Rs)1,190.10 | Open (Rs) 1,205.00 | High (Rs) 1,230.00 | Low (Rs) 1,189.00 |
% Change-0.18 | Volume 1,800 | Value (Rs) 2,142,180 | 52-Week H/L 1,595.00 / 660.00 |
BSE Sensex | CNX Nifty |
BETA DRUGS last traded price was down 0.2% to Rs 1,190.1 on the NSE. The total volume of shares traded was 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.6%. And the benchmark NIFTY 50 was at 22,502.0 (up 0.2%).
Over the last 30 days, the BETA DRUGS share price is down 13.8%.
As of March 2024, company promoters held 66.73% stake in BETA DRUGS , with no shares having been pledged. To know more, check out the latest shareholding pattern of BETA DRUGS .
On the NSE, BETA DRUGS last traded price was down 0.2% at Rs 1,190.1.
For the financial year 2023, BETA DRUGS declared dividend amounting to Rs 0.0 per share. At the current price of Rs 1,190.1, this results in a dividend yield of 0.0%.
Based on marketcap, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks ranked by marketcap here.
Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.
Based on sales, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.
Based on net profit, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.
Indian share markets ended the mock trading session on a positive note tracking strong global peers and FII inflows.